Top-News
Gesundheitswesen: Ausstattung u. Produkte USA

Transmedics Group News

Aktie
WKN:  A2PH5P ISIN:  US89377M1099 US-Symbol:  TMDX
138,50 €
+0,00 €
0,00%
08:04:52 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
32,63 Mio.
Marktkapitalisierung *
4,51 Mrd. €
Streubesitz
-11,65%
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 27.08.2023

Transmedics Group News

21.06.24 - PR Newswire
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
17.05.24 - PR Newswire
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
30.04.24 - PR Newswire
TransMedics Reports First Quarter 2024 Financial Results
TransMedics Reports First Quarter 2024 Financial Results PR Newswire
16.04.24 - PR Newswire
TransMedics to Report First Quarter 2024 Financial Results on April 30, 2024
TransMedics to Report First Quarter 2024 Financial Results on April 30, 2024 PR Newswire
08.04.24 - PR Newswire
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
19.03.24 - PR Newswire
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
02.03.24 - PR Newswire
TMDX INVESTOR NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation - TMDX
TMDX INVESTOR NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation - ...
28.02.24 - PR Newswire
TransMedics to Present at Upcoming March Investor Conferences
TransMedics to Present at Upcoming March Investor Conferences PR Newswire
28.02.24 - PR Newswire
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
27.02.24 - PR Newswire
Thinking about trading options or stock in Alphabet Inc, Autozone, Zoom Video Communications, TransMedics Group, or Viking Therapeutics?
Thinking about trading options or stock in Alphabet Inc, Autozone, Zoom Video Communications, TransMedics Group, or Viking Therapeutics? PR Newswire
26.02.24 - PR Newswire
TransMedics Reports Fourth Quarter and Full Year 2023 Financial Results
TransMedics Reports Fourth Quarter and Full Year 2023 Financial Results PR Newswire
16.02.24 - PR Newswire
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
12.02.24 - PR Newswire
TransMedics to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
TransMedics to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024 PR Newswire
16.01.24 - PR Newswire
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
18.12.23 - PR Newswire
TransMedics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
TransMedics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference PR Newswire
12.12.23 - PR Newswire
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
14.11.23 - PR Newswire
TransMedics to Present at the Piper Sandler 35th Annual Healthcare Conference
TransMedics to Present at the Piper Sandler 35th Annual Healthcare Conference PR Newswire
07.11.23 - PR Newswire
Thinking about buying stock in Immix Biopharma, Vista Energy, Enphase Energy, TransMedics, or Medavail Holdings?
Thinking about buying stock in Immix Biopharma, Vista Energy, Enphase Energy, TransMedics, or Medavail Holdings? PR Newswire
06.11.23 - PR Newswire
TransMedics Reports Third Quarter 2023 Financial Results
TransMedics Reports Third Quarter 2023 Financial Results PR Newswire
03.11.23 - PR Newswire
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire

Newssuche

Videos

newspaper
03.07.24
Technical Trading: Bund Future Long Chance
Bund Future Long Typ: Turbo Open End WKN: VM3CG4 Hebel: 7,32 Laufzeit: OpenEnd Einstieg: Market ... Mehr »